This Federal Supply Schedule (FSS) contract awarded to Indivior Inc. provides the Department of Veterans Affairs (VA) with a $131.9 million ceiling value Indefinite Delivery Vehicle (IDV) to procure various drugs, pharmaceuticals, and hematology-related products through June 2025. As the prime contractor, Indivior Inc. is a for-profit pharmaceutical manufacturer that specializes in developing treatments for opioid use disorder and overdose.
Under this multiple-award FSS contract, Indivior has previously received delivery orders from the VA for its Sublocade medication to treat opioid use disorder. The company has also provided the Department of Health and Human Services with an intranasal nalmefene drug-device combination product to treat opioid overdoses through a separate $110.7 million cost-plus-fixed-fee contract. Additionally, Indivior has received research grants from the National Institute on Drug Abuse to conduct clinical evaluations and development of a non-opioid treatment for opioid use disorder. This FSS IDV allows the VA to order a range of medical supplies from Indivior and other contracted vendors as needed, without any set-aside designations.
Generated 12/17/24, 9:06 AM